Kirstein MM - Search Results

1

Activity of the mTOR inhibitor RAD001, the dual mTOR and PI3-kinase inhibitor BEZ235 and the PI3-kinase inhibitor BKM120 in hepatocellular carcinoma.

Kirstein MM, Boukouris AE, Pothiraju D, Buitrago-Molina LE, Marhenke S, Schütt J, Orlik J, Kühnel F, Hegermann J, Manns MP, Vogel A. Kirstein MM, et al. Liver Int. 2013 May;33(5):780-93. doi: 10.1111/liv.12126. Epub 2013 Mar 15. Liver Int. 2013. PMID: 23489999

2

A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer.

Lange A, Prenzler A, Frank M, Kirstein M, Vogel A, von der Schulenburg JM. Lange A, et al. Eur J Cancer. 2014 Jan;50(1):40-9. doi: 10.1016/j.ejca.2013.08.008. Epub 2013 Sep 4. Eur J Cancer. 2014. PMID: 24011538 Review.

3

[Aspirin and PIK3CA mutation in colorectal cancer].

Kirstein MM, Vogel A. Kirstein MM, et al. Z Gastroenterol. 2014 Mar;52(3):306-7. doi: 10.1055/s-0033-1356386. Epub 2014 Mar 12. Z Gastroenterol. 2014. PMID: 24622874 German. No abstract available.

4

The pathogenesis of hepatocellular carcinoma.

Kirstein MM, Vogel A. Kirstein MM, et al. Dig Dis. 2014;32(5):545-53. doi: 10.1159/000360499. Epub 2014 Jul 14. Dig Dis. 2014. PMID: 25034287 Review.

5

[RAS testing in metastatic colorectal cancer].

Kirstein MM, Vogel A. Kirstein MM, et al. Z Gastroenterol. 2014 Sep;52(9):1095-6. doi: 10.1055/s-0034-1384878. Epub 2014 Sep 8. Z Gastroenterol. 2014. PMID: 25198090 German. No abstract available.

6

Targeted therapies in metastatic colorectal cancer: a systematic review and assessment of currently available data.

Kirstein MM, Lange A, Prenzler A, Manns MP, Kubicka S, Vogel A. Kirstein MM, et al. Oncologist. 2014 Nov;19(11):1156-68. doi: 10.1634/theoncologist.2014-0032. Epub 2014 Oct 17. Oncologist. 2014. PMID: 25326159 Free PMC article.

7

Long-lasting tumour response to sorafenib therapy in advanced hepatocellular carcinoma.

Kirstein MM, Schweitzer N, Schmidt S, Klöpper A, Ringe KI, Lehmann U, Manns MP, Wedemeyer H, Vogel A. Kirstein MM, et al. Acta Gastroenterol Belg. 2014 Dec;77(4):386-8. Acta Gastroenterol Belg. 2014. PMID: 25682626 Free article.

8

Prediction of short- and long-term outcome in patients with autoimmune hepatitis.

Kirstein MM, Metzler F, Geiger E, Heinrich E, Hallensleben M, Manns MP, Vogel A. Kirstein MM, et al. Hepatology. 2015 Nov;62(5):1524-35. doi: 10.1002/hep.27983. Epub 2015 Aug 25. Hepatology. 2015. PMID: 26178791

9

Experience from a real-life cohort: outcome of 606 patients with hepatocellular carcinoma following transarterial chemoembolization.

Kirstein MM, Schweitzer N, Ay N, Boeck C, Lappas K, Hinrichs JB, Voigtländer T, Wacker F, Manns MP, Rodt T, Vogel A. Kirstein MM, et al. Scand J Gastroenterol. 2017 Jan;52(1):116-124. doi: 10.1080/00365521.2016.1233579. Epub 2016 Sep 22. Scand J Gastroenterol. 2017. PMID: 27598949

10

Transarterial Chemoembolization versus Resection in Patients with Large, Solitary Hepatocellular Carcinoma.

Kirstein MM, Vogel A. Kirstein MM, et al. J Vasc Interv Radiol. 2016 Nov;27(11):1773-1774. doi: 10.1016/j.jvir.2015.10.027. J Vasc Interv Radiol. 2016. PMID: 27926422 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page